Peripheral Vasodilator Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033
The Business Research Company’s Peripheral Vasodilator Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033
LONDON, GREATER LONDON, UK, August 16, 2024 /EINPresswire.com/ -- The peripheral vasodilator drugs market has experienced robust growth in recent years, expanding from $5.92 billion in 2023 to $6.27 billion in 2024 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, and growing patient preference for non-surgical or minimally invasive treatment options.
Strong Future Growth Anticipated
The peripheral vasodilator drugs market is projected to continue its strong growth, reaching $7.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, and timely regulatory approvals for new structural heart devices.
Explore Comprehensive Insights Into The Global Peripheral Vasodilator Drugs Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16508&type=smp
Growth Driver Of The Peripheral Vasodilator Drugs Market
An increase in the prevalence of cardiovascular diseases is expected to propel the growth of the peripheral vasodilator drug market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, often caused by atherosclerosis, leading to conditions like heart attacks, strokes, hypertension, and heart failure. The cases of cardiovascular diseases arise primarily due to sedentary lifestyles, unhealthy diets, aging populations, rising rates of obesity, and related health conditions such as diabetes and hypertension. Peripheral vasodilators in cardiovascular diseases improve blood flow, reduce blood pressure, decrease the heart’s workload, and alleviate symptoms of conditions such as peripheral arterial disease.
Order Your Report Now For Swift Delivery:
https://www.thebusinessresearchcompany.com/report/peripheral-vasodilator-drugs-global-market-report
Major Players And Market Trends
Key players in the peripheral vasodilator drugs market include Pfizer Inc., Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc.
Major companies operating in the peripheral vasodilator drugs market are focusing on drug development with triple-drug combination therapies to optimize treatment outcomes and expand market share in cardiovascular therapeutics. Triple-drug combination therapy is an antihypertensive FDC that targets patients who have not achieved adequate blood pressure control with dual-drug therapies or are unable to tolerate diuretic-based combinations.
Segments:
1) By Drug Type: Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types
2) By Indication: Hypertension, Angina, Heart Failure, Other Indications
3) By Application: Hospital, Retail Pharmacies, Other Applications
Geographical Insights: North America Leading The Market
North America was the largest region in the peripheral vasodilator drugs market in 2023. The regions covered in the peripheral vasodilator drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Peripheral Vasodilator Drugs Market Definition
Peripheral vasodilator drugs refer to medications that primarily act on blood vessels outside of the heart and brain, specifically targeting the peripheral circulation. These drugs are used to widen (dilate) blood vessels, thereby reducing resistance to blood flow and lowering blood pressure.
Peripheral Vasodilator Drugs Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Peripheral Vasodilator Drugs Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on peripheral vasodilator drugs market size, peripheral vasodilator drugs market drivers and trends, peripheral vasodilator drugs market major players, peripheral vasodilator drugs competitors' revenues, peripheral vasodilator drugs market positioning, and peripheral vasodilator drugs market growth across geographies. The peripheral vasodilator drugs market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Peripherally Inserted Central Catheter (PICC) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/peripherally-inserted-central-catheter-picc-global-market-report
Narcotics Scanner Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/narcotics-scanner-global-market-report
Narcotic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report
About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
